paul dobrowski

Synthego co-founder Paul Dabrowski is coming to Disrupt New York 2017

Genetic engineering startup Synthego makes synthetic ribonucleic acid (RNA), an important genetic component found in all living cells and also used in CRISPR Cas9, a technology enabling scientists to